These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2. Sacher F, Probst V, Maury P, Babuty D, Mansourati J, Komatsu Y, Marquie C, Rosa A, Diallo A, Cassagneau R, Loizeau C, Martins R, Field ME, Derval N, Miyazaki S, Denis A, Nogami A, Ritter P, Gourraud JB, Ploux S, Rollin A, Zemmoura A, Lamaison D, Bordachar P, Pierre B, Jaïs P, Pasquié JL, Hocini M, Legal F, Defaye P, Boveda S, Iesaka Y, Mabo P, Haïssaguerre M. Circulation; 2013 Oct 15; 128(16):1739-47. PubMed ID: 23995538 [Abstract] [Full Text] [Related]
4. Implantable cardioverter-defibrillator therapy in Brugada syndrome: a 20-year single-center experience. Conte G, Sieira J, Ciconte G, de Asmundis C, Chierchia GB, Baltogiannis G, Di Giovanni G, La Meir M, Wellens F, Czapla J, Wauters K, Levinstein M, Saitoh Y, Irfan G, Julià J, Pappaert G, Brugada P. J Am Coll Cardiol; 2015 Mar 10; 65(9):879-88. PubMed ID: 25744005 [Abstract] [Full Text] [Related]
11. [Brugada syndrome--underestimated cause of sudden cardiac death in patients without an organic cardiac disease--a case report]. Kołodziej M, Sledź J, Janion M. Kardiol Pol; 2009 Feb 10; 67(2):159-61. PubMed ID: 19288378 [Abstract] [Full Text] [Related]
13. Circadian and seasonal variations of ventricular tachyarrhythmias in patients with early repolarization syndrome and Brugada syndrome: analysis of patients with implantable cardioverter defibrillator. Kim SH, Nam GB, Baek S, Choi HO, Kim KH, Choi KJ, Joung B, Pak HN, Lee MH, Kim SS, Park SJ, On YK, Kim JS, Oh IY, Choi EK, Oh S, Choi YS, Choi JI, Park SW, Kim YH, Lee MY, Lim HE, Lee YS, Cho Y, Kim J, Lee DI, Cho DK, Kim YH. J Cardiovasc Electrophysiol; 2012 Jul 10; 23(7):757-63. PubMed ID: 22353358 [Abstract] [Full Text] [Related]
15. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram. Kyriazis K, Bahlmann E, van der Schalk H, Kuck KH. Europace; 2009 May 10; 11(5):665-6. PubMed ID: 19346290 [Abstract] [Full Text] [Related]
16. Refractoriness to subcutaneous implantable cardioverter defibrillator after frequent therapies for ventricular fibrillation storms in a Brugada syndrome case. Nakao Y, Suenari K, Yamashiro K, Nakagawa H, Shiode N. BMC Cardiovasc Disord; 2020 Mar 13; 20(1):134. PubMed ID: 32169057 [Abstract] [Full Text] [Related]
18. [The electrophysiological study and implantable cardioverter defibrillator therapy for the patients with Brugada syndrome]. Shan QJ, Yang B, Chen ML, Zou JG, Xu DJ, Chen C, Li KL, Zhu PJ, Wang XB, Cao KJ. Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan 13; 33(1):34-6. PubMed ID: 15924775 [Abstract] [Full Text] [Related]
19. Outcome after implantation of cardioverter defibrillator [corrected] in patients with Brugada syndrome: a multicenter Israeli study (ISRABRU). Rosso R, Glick A, Glikson M, Wagshal A, Swissa M, Rosenhek S, Shetboun I, Khalamizer V, Fuchs T, Boulos M, Geist M, Strasberg B, Ilan M, Belhassen B, Israeli Working Group on Cardiac Pacing and Electrophysiology. Isr Med Assoc J; 2008 Jun 13; 10(6):435-9. PubMed ID: 18669142 [Abstract] [Full Text] [Related]